♦ Pharmaceutical Intermediates
| Product | CAS No. | Application |
| (7alpha,17beta)-17-(Acetyloxy)-7-(9-bromononyl)estr-4-en-3-one | 875573-63-0 | Fulvestrant |
| (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate | 875573-69-6 | Fulvestrant |
| (7a,17b)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate | 875573-66-3 | Fulvestrant |
| (7a,17b)-7-(9-Bromononyl)estra-1,3,5(10)-triene-3,17-diol | 875573-67-4 | Fulvestrant |
| (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol | 153004-31-0 | Fulvestrant |
| 1-[2-Fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione | 830346-47-9 | Elagolix |
| 1-(2-Fluoro-6-(trifluoromethyl)benzyl)urea | 830346-46-8 | Elagolix |
| 4-(2-Fluoro-4-nitrophenyl)morpholine | 2689-39-6 | Linezolid |
| 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one | 1016636-76-2 | Palbociclib |
| 2-(4-Fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene | 898566-17-1 | Canagliflozin |
| 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 | Canagliflozin |
| (S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran | 915095-94-2 | Empagliflozin |
| 2-(Bromomethyl)-3,4-difluoro-1-methoxybenzene | 886501-83-3 | |
| 4-Fluoro-5-nitro-2-methoxyphenol | 935286-13-8 | |
| 4-[(Phenoxycarbonyl)amino]-2,3-thiophenedicarboxylic acid 2,3-dimethyl ester | 1581731-15-8 |

